Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging
- Authors
- Park, Jinho; Kim, Sunghyun; Saw, Phei Er; Lee, In-Hyun; Yu, Mi Kyung; Kim, Minsik; Lee, Kwangyeol; Kim, Yong-Chul; Jeong, Yong Yeon; Jon, Sangyong
- Issue Date
- 28-10월-2012
- Publisher
- ELSEVIER SCIENCE BV
- Keywords
- Aptide; Fibronectin extra domain; SPION; MRI; Cancer imaging
- Citation
- JOURNAL OF CONTROLLED RELEASE, v.163, no.2, pp.111 - 118
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CONTROLLED RELEASE
- Volume
- 163
- Number
- 2
- Start Page
- 111
- End Page
- 118
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/107178
- DOI
- 10.1016/j.jconrel.2012.08.029
- ISSN
- 0168-3659
- Abstract
- Fibronectin extra domain B (EDB) is specifically expressed in cancer-associated blood vessels and extracellular matrix, and thus is a promising cancer biomarker. Very recently, we developed a novel class of high-affinity (<100 nM) peptides, termed 'aptides', that specifically bind a variety of protein targets. Here, we describe superparamagnetic iron oxide nanoparticles (SPIONs) conjugated with EDB-specific aptides for use in targeted magnetic resonance imaging (MRI) of cancer. An anti-EDB aptide (APT(EDB)) containing an additional cysteine residue reacted with maleimide-terminated, PEGylated phospholipid (Mal-PEG(2000)-DSPE) to give an aptide-conjugated PEGylated phospholipid (APT(EDB)-PEG(2000)-DSPE). A nanoemulsion method was then used to coat oleic acid-stabilized SPIONs with amphiphilic phospholipids, including APT(EDB)-PEG(2000)-DSPE, methoxy-PEG(2000)-DSPE, and rhodamine-DMPE. The resulting nanoparticles (APT(EDB)-SPIONs) had a hydrodynamic size of less than 50 nm and remained stable in an aqueous solution for at least 1 week. In in vitro studies, APT(EDB)-SPIONs showed specific uptake by EDB-overexpressing cell lines. In an in vivo Lewis lung carcinoma model that expresses a high level of the target EDB protein, MRI clearly revealed that APT(EDB)-SPIONs injected via the tail vein specifically accumulated at the tumor site. Non-targeting SPIONs lacking the anti-EDB aptide showed much lower uptake in tumor tissues than did aptide-conjugated nanoparticles. Further, we confirmed that the distribution of nanoparticles within the tumor tissue was well correlated with the areas where EDB was expressed. Our APT(EDB)-SPIONs hold high potential as a specific imaging modality for the detection of EDB-overexpressing tumors. (c) 2012 Elsevier B.V. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Science > Department of Chemistry > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.